ECE2017 Oral Communications Diabetes therapy and complications (5 abstracts)
Copeptin and its association to cardiovascular dysfunction in type 2 diabetes
Simona Ioana Chisalita 1 , Lee Ti Chong 2 , Fredrik Nyström 1 , Carl Johan Östgren 3 & Toste Länne 4
1Department of Endocrinology and Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden; 2Department of Emergency and Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden; 3Department of Medical and Health Sciences (IMH)/Division of Community, Linköping, Sweden; 4Department of Thoracic and Vascular Surgery, and Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Background: We aim to test whether plasma copeptin (copeptin), the C-terminal fragment of vasopressin, has predictive value of cardiovascular events in patients with type 2 diabetes without previous cardiovascular disease who were treated in primary care.
Methods: We measured copeptin in 697 patients who participated in the epidemiological study CARDIPP (Cardiovascular Risk Factors in Patients with Diabetes – a Prospective Study in Primary Care; ClinicalTrials.gov identifier NCT01049737) and who did not have previously known myocardial infarction or stroke. The outcome variable was a composite endpoint consisting of cardiovascular mortality, hospitalization for myocardial infarction and hospitalization for stroke.
Results: During a median follow-up time of almost 7 years, the unadjusted HR per each increment of Copeptin by 1 pmol/l was 3.5 (95% CI 1.7–7.1, P<0.001) for the primary endpoint. Following adjustments for age, sex, HbA1c, arterial stiffness (PWW) as well as atherosclerosis plaque the adjusted hazard ratio was 2.4 (95% CI 1.1–5.2, P=0.03).
Conclusions: In primary preventive patients with type 2 diabetes treated in primary care, copeptin predicted a composite outcome of incident cardiovascular events independently of age, sex, HbA1c, arterial stiffness as well as atherosclerosis plaque.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more